Table 4.
Patients Characteristics n = 167 |
Median | IQR |
---|---|---|
Age [years] | 48 | 24 |
Men [%] | 29 | - |
Benign nodules [%] | 79 | - |
Thyroid cancers [%] | 21 | - |
Body mass index (BMI) [kg/m2], * (18.5–25) | 27.76 | 7.79 |
TSH [uIU/mL], * (0.27–2.4) | 1.29 | 0.78 |
Creatinine [mg/dL], * (0.5–0.9) | 0.72 | 0.18 |
FT3 [pg/mL], * (2–4.4) | 3.16 | 0.46 |
FT4 [ng/dL], * (0.93–1.7) | 1.28 | 0.29 |
PTH [pg/mL], * (15–65) | 19.7 | 22.18 |
Ca [mmol/L], * (1.0–1.3) | 1.19 | 0.16 |
25-OHD [ng/mL], * (0–30) | 6.13 | 2.51 |
1,25-(OH)2D [pg/mL] * (20–60) | 48.69 | 15.17 |
VDBP [ng/mL] | 30.12 | 14.13 |
* ()—normal range.